Detalhe da pesquisa
1.
Burden of Illness of Type 2 Diabetes Mellitus in the Kingdom of Saudi Arabia: A Five-Year Longitudinal Study.
Adv Ther
; 41(3): 1120-1150, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240948
2.
The Saudi consensus recommendations for the management of psoriatic arthritis (2023).
Clin Rheumatol
; 43(3): 879-894, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38217738
3.
Informing a cost-effectiveness threshold for Saudi Arabia.
J Med Econ
; 26(1): 128-138, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36576804
4.
Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023).
Dermatol Ther (Heidelb)
; 13(10): 2129-2151, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37558830
5.
Cost of cardiovascular diseases and renal complications in people with type 2 diabetes mellitus in the Kingdom of Saudi Arabia: A retrospective analysis of claims database.
PLoS One
; 17(10): e0273836, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36264903
6.
Restriction on antimicrobial dispensing without prescription on a national level: Impact on the overall antimicrobial utilization in the community pharmacies in Saudi Arabia.
PLoS One
; 17(7): e0271188, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35881572
7.
Recommendations for the treatment of rheumatoid arthritis in Saudi Arabia: adolopment of the 2021 American College of Rheumatology guidelines.
BMC Rheumatol
; 6(1): 70, 2022 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36414983
8.
Saudi consensus statement on biologic treatment of chronic plaque psoriasis (2020).
J Dermatolog Treat
; 33(4): 1916-1930, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34284704
9.